日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma

EV-101:恩福妥单药治疗Nectin-4阳性实体瘤(包括转移性尿路上皮癌)患者的I期研究

Rosenberg, Jonathan; Sridhar, Srikala S; Zhang, Jingsong; Smith, David; Ruether, Dean; Flaig, Thomas W; Baranda, Joaquina; Lang, Joshua; Plimack, Elizabeth R; Sangha, Randeep; Heath, Elisabeth I; Merchan, Jamie; Quinn, David I; Srinivas, Sandy; Milowsky, Matthew; Wu, Chunzhang; Gartner, Elaina M; Zuo, Peiying; Melhem-Bertrandt, Amal; Petrylak, Daniel P

A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma

一项针对局部晚期或转移性尿路上皮癌日本患者的恩福妥单抗I期研究

Takahashi, Shunji; Uemura, Motohide; Kimura, Tomokazu; Kawasaki, Yoshihide; Takamoto, Atsushi; Yamaguchi, Akito; Melhem-Bertrandt, Amal; Gartner, Elaina M; Inoue, Takashi; Akazawa, Rio; Kadokura, Takeshi; Tanikawa, Toshiki

Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy

铂类和抗程序性死亡受体1/程序性死亡配体1(PD-1/PD-L1)治疗后尿路上皮癌的关键性试验

Rosenberg, Jonathan E; O'Donnell, Peter H; Balar, Arjun V; McGregor, Bradley A; Heath, Elisabeth I; Yu, Evan Y; Galsky, Matthew D; Hahn, Noah M; Gartner, Elaina M; Pinelli, Juan M; Liang, Shang-Ying; Melhem-Bertrandt, Amal; Petrylak, Daniel P

A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma

SGN-CD70A治疗CD70阳性弥漫性大B细胞淋巴瘤和套细胞淋巴瘤患者的I期临床试验

Phillips, Tycel; Barr, Paul M; Park, Steven I; Kolibaba, Kathryn; Caimi, Paolo F; Chhabra, Saurabh; Kingsley, Edwin C; Boyd, Thomas; Chen, Robert; Carret, Anne-Sophie; Gartner, Elaina M; Li, Hong; Yu, Cindy; Smith, David C

A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer

一项针对转移性或局部晚期不可切除乳腺癌的17-烯丙基氨基-17-去甲氧基格尔德霉素的II期研究

Gartner, Elaina M; Silverman, Paula; Simon, Michael; Flaherty, Lawrence; Abrams, Judith; Ivy, Percy; Lorusso, Patricia M

A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer.

一项关于抗血管生成降铜剂四硫钼酸盐与伊立替康、5-氟尿嘧啶和亚叶酸钙联合治疗转移性结直肠癌的试点试验

Gartner Elaina M, Griffith Kent A, Pan Quintin, Brewer George J, Henja Gwen F, Merajver Sofia D, Zalupski Mark M